Skip to content

Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial

Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029788
Enrollment
Unknown
Registered
2020-02-13
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of the "New Coronavirus Pneumonia Diagnosis and Treatment Scheme", patients with pneumonia confirmed by new coronavirus infection; 2. Pneumonia Severity Index (PSI) grade is I ~ II; 3. Aged 18-80 years; 4. Those who have signed the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. People with allergies and allergies to experimental drugs; 2. Combined with other malignant tumors; 3. Patients with hematological diseases, coagulopathy and autoimmune diseases; 4. Combined with severe cardiovascular diseases, Patients with vascular disease, hematopoietic system disease, and neuropathy; 5. Participated in other clinical researchers 3 months before the trial.

Design outcomes

Primary

MeasureTime frame
Antipyretic time;Pharyngeal swab nucleic acid negative time;Blood gas analysis;Traditional Chinese medicine syndrome score;

Countries

China

Contacts

Public ContactYaosheng Zhang, Jianwei Shang

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

zysjsgzs@163.com+86 18134048843

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026